Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Completed · Phase 4

Conditions studied: Rheumatoid Arthritis

In brief

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

Key facts

Study ID

NCT00234897

Run by

Abbott

People needed

1938

Starts

2004-08-01

Last updated by the study team

2007-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
• Subject, based on assessment of investigator, meets the definition of active RA

You may not qualify if…

• Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
• Female subject who is pregnant or breast-feeding or considering becoming pregnant

Where it is running

• Global Medical Information - Abbott — North Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.